Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam plus atropine versus atropine alone for premedication before neonatal endotracheal intubation
IRCT20130329012869N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of midazolam and atropine in respiratory distress syndrome (RDS) and None (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pain score, Heart rate and 4 more. Started Jul 2019; status: completed.
02
Drugs
midazolamatropine
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20130329012869N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130329012869N2.